Neoleukin Therapeutics, Inc. (formerly Aquinox Pharmaceuticals, Inc.)
Profile
Mailing Address: 887 Great Northern Way
Suite 450
Vancouver, British Columbia
V5T 4T5
Head Office Address: 401 Terry Avenue North
Seattle, Washington
98109
Contact Name: Kamran Alam Principal Regulator: British Columbia
Business e-mail address: kalam@neoleukin.com Short Form Prospectus Issuer: Yes
Telephone Number: 604 629-9223 Reporting Jurisdictions: British Columbia, Alberta, Ontario
Fax Number: 778 331-4486 Stock Exchange: NASDAQ
Date of Formation: May 25 2007 Stock Symbol: NLTX
Jurisdiction Where Formed: Delaware Auditor: Deloitte LLP
Industry Classification: consumer products - biotechnology/pharmaceuticals General Partner:
CUSIP Number: 03842B Transfer Agent: American Stock Transfer & Trust Company, LLC
Financial Year-End: Dec 31 Size of Issuer (Assets): $25,000,001 to $100,000,000


View This Company's Documents